Filing Details

Accession Number:
0001661181-19-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-05 20:11:17
Reporting Period:
2019-09-03
Accepted Time:
2019-09-05 20:11:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661181 Organogenesis Holdings Inc. ORGO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1244191 H Glenn Nussdorf 35 Sawgrass Drive
Bellport NY 11713
Yes No Yes No
1760694 Starr Wisdom 44 Wilson Street
Hartsdale NY 10530
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2019-09-03 50,000 $4.38 67,896,723 No 4 P Direct
Class A Common Stock Acquisiton 2019-09-03 100 $4.25 67,896,823 No 4 P Direct
Class A Common Stock Acquisiton 2019-09-04 50,000 $4.62 67,946,823 No 4 P Direct
Class A Common Stock Acquisiton 2019-09-05 5,000 $4.53 67,951,823 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The reported securities were purchased and are held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below).
  2. The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.48, inclusive. The reporting person undertakes to provide to Organogenesis Holdings Inc. ("ORGO"), any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  3. The reported securities were purchased and are held directly by Dennis Erani, who is a member of the Group.
  4. The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.92, inclusive. The reporting person undertakes to provide to ORGO, any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. The reported securities were purchased and are held directly by Albert Erani, who is a member of the Group.
  6. The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.52 to $4.55, inclusive. The reporting person undertakes to provide to ORGO, any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (6) to this Form 4.